Apex Biotechnology Corp. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was TWD 509.593 million compared to TWD 465.758 million a year ago. Operating income was TWD 29.692 million compared to TWD 2.865 million a year ago. Net income was TWD 23.110 million compared to net loss of TWD 16.618 million a year ago. Basic earnings per share was TWD 0.23 compared to basic loss per share of TWD 0.17 a year ago. Diluted earnings per share was TWD 0.21 compared to diluted loss per share of TWD 0.17 a year ago. For the nine months, sales was TWD 1,550.607 million compared to TWD 1,532.452 million a year ago. Operating income was TWD 76.821 million compared to TWD 67.931 million a year ago. Net income was TWD 61.838 million compared to TWD 33.069 million a year ago. Basic earnings per share was TWD 0.62 compared to TWD 0.33 a year ago. Diluted earnings per share was TWD 0.57 compared to TWD 0.32 a year ago.